Skills this job asks for
Supply chainProject managementCompliance
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Ultragenyx Pharmaceutical INC paid sponsored hires in similar roles2 certified filings for “Senior Director, CMC Quality Assurance” (Industrial Production Managers) in MA: $145k–$179k, median $162k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Ultragenyx Pharmaceutical INC paid sponsored hires in similar roles
- 2 certified filings for “Senior Director, CMC Quality Assurance” (Industrial Production Managers) in MA: $145k–$179k, median $162k. Most were filed at wage level II (50%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Why Join Us?
Be a hero for our rare disease patients
At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them.
Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work. Ultimately, we want to be an organization where we would be proud for our family, friends and children to work.
If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team .
Position Summary:
ultra dedicated – Your biggest challenges yield rare possibilities
Reporting to the Executive Director, Supply Chain Management , Ultragenyx is seeking a highly motivated Senior Director of Supply Chain Management (SCM) with expertise in end-to-end pharmaceutical program supply chain management for gene therapy . In this position you will be responsible for strategy, development, and oversight of demand and supply for gene therapy programs for all life cycle stages . You will partner with Commercial, Clinical, Manufacturing, Packaging and Labeling, Regulatory, Quality and Program Management to ensure supply across a global network .
Work Model:
Flex: This role will typically require onsite work 2-3 days each week, or more depending on business needs. In many locations, the business will set certain days each week that Flex employees are required to be onsite.
Responsibilities:
• Accountable for end-to-end gene therapy supply in partnership with the Program Team Leads and Global Commercial Leads. Responsibilities include, but not limited to, supply chain network strategy development and implementation, multi-stage (i.e., from raw materials through finished goods) demand and supply oversight, and on time in full supply execution.
• Develop strategies to deliver quality supply throughout product life cycle in collaboration with Commercial, Clinical, Manufacturing, Packaging, Quality, Regulatory, and Project Management. Proactively directs supply life cycle changes, ensuring resource requirements and risks are clearly identified within the Ultragenyx Decision Making Framework.
• Key stakeholder for both internal and external gene therapy manufacturing. Consulted in contract development and execution for contract organizations. Liaise with Contract Organization (CO) business owners to ensure schedules meet product objectives.
• Represent end-to-end gene therapy supply in Sales / Demand & Operations Planning (S/D&OP) process. Ensure S/D&OP plans align with company and product strategy and milestones. Provide connection between D/S&OP and CMC sub-team.
• Single point of contact for Supply Chain Management to CMC sub-team lead, maintain strong communication between SCM and the CMC team.
• Responsible for gene therapy Supply Chain compliance with processes and documentation to enable GxP product supply, including completion of Clinical Trial Master Files and adherence to finance requirements.
• Accountable for pro
Apply on employer site ↗